Last update 21 Nov 2024

PSN-9301

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [3]
Target
DPP-4
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Originator Organization
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Organization-
Inactive Organization
Astellas Pharma, Inc.Astellas Pharma, Inc.Prosidion Ltd.
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with PSN-9301
EUCTR2004-002701-68-DE / Not yet recruitingNot Applicable
A randomised, double-blind, placebo-controlled, multiple dose, time-lagged parallel groups trial, investigating the pharmacodynamics, the safety and tolerability and the pharmacokinetics of PSN9301 in type 2 diabetes patients - Not available
100 Clinical Results associated with PSN-9301
Login to view more data
100 Translational Medicine associated with PSN-9301
Login to view more data
100 Patents (Medical) associated with PSN-9301
Login to view more data
1
Literatures (Medical) associated with PSN-9301
01 Apr 2007Current opinion in investigational drugs (London, England : 2000)
Drug evaluation: PSN-9301, a short-acting inhibitor of dipeptidyl peptidase IV.
100 Deals associated with PSN-9301
Login to view more data

External Link

KEGGWikiATCDrug Bank
---
DB05001

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2-
Astellas Pharma, Inc.Astellas Pharma, Inc.
-
Diabetes Mellitus, Type 2Phase 2
DE
Prosidion Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free